NTRK GENE FUSION CANCER

NTRK GENE FUSION CANCER was reported 4 times

NTRK GENE FUSION CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Opioid Agonist [EPC] 2 0.0000
1 Alkylating Drug [EPC] 1 0.0000
2 Kinase Inhibitor [EPC] 2 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000